Literature DB >> 9466601

Ophthalmoplegic and lower cranial nerve variants merge into each other and into classical Guillain-Barré syndrome.

J P Ter Bruggen1, F G van der Meché, A E de Jager, C H Polman.   

Abstract

We delineated the place of cranial nerve variants within the concept of clinically defined Guillain-Barre syndrome (GBS). In the ophthalmoplegic variant (n = 7) the oculomotor nerves were early involved. In a lower cranial nerve variant (n = 9) the cranial nerves IX, X, and XI were early involved. During progression considerable overlap occurred between these two variants, but also with the classically ascending variant of clinically defined GBS. These findings indicate common immune mechanisms in all GBS variants.

Mesh:

Year:  1998        PMID: 9466601     DOI: 10.1002/(sici)1097-4598(199802)21:2<239::aid-mus13>3.0.co;2-x

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  Variants of Guillain-Barré syndrome: low incidence but high impact.

Authors:  Helmar C Lehmann; Hans-Peter Hartung
Journal:  J Neurol       Date:  2009-07-25       Impact factor: 4.849

2.  Unilateral third nerve palsy caused by Guillain-Barré Syndrome.

Authors:  Erik K St Louis; Daniel M Jacobson
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.

Authors:  C S Goodyear; G M O'Hanlon; J J Plomp; E R Wagner; I Morrison; J Veitch; L Cochrane; R W Bullens; P C Molenaar; J Conner; H J Willison
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  Diagnostic value of anti-GQ1b antibodies in a patient with relapsing dysarthria and ataxia.

Authors:  Mark Kuijf; Liselotte Ruts; Pieter A van Doorn; Peter J Koudstaal; Bart C Jacobs
Journal:  BMJ Case Rep       Date:  2009-03-17

Review 5.  Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective.

Authors:  Graham M O'Hanlon; Roland W M Bullens; Jaap J Plomp; Hugh J Willison
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

6.  Anti-GT1a IgG in Guillain-Barré syndrome.

Authors:  M Koga; H Yoshino; M Morimatsu; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

7.  Potential misdiagnoses of Bell's palsy in the emergency department.

Authors:  Jahan Fahimi; Babak B Navi; Hooman Kamel
Journal:  Ann Emerg Med       Date:  2013-07-25       Impact factor: 5.721

8.  Pharyngeal-Cervical-Brachial variant of Guillian-Barre Syndrome in Children.

Authors:  Ravi R Pradhan; Sant K Yadav; Shreebodh K Yadav
Journal:  Cureus       Date:  2020-02-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.